TABLE 3.
Association between BIH (Bevacizumab-Induced Hypertension) and first-line bevacizumab-based chemotherapy.
BIH | |||
No (%) | Yes (%) | P | |
Disease control | |||
No | 22 (33.8) | 2 (5.7) | |
Yes | 43 (66.2) | 33 (94.3) | 0.0018 |
Association between BIH (Bevacizumab-Induced Hypertension) and first-line bevacizumab-based chemotherapy.
BIH | |||
No (%) | Yes (%) | P | |
Disease control | |||
No | 22 (33.8) | 2 (5.7) | |
Yes | 43 (66.2) | 33 (94.3) | 0.0018 |